Zealand is a Danish biotechnology company with 25 years of expertise in discovering, designing, and developing peptide-based drugs
The restricted cubic splines model consistently indicated positive doseresponse relationships between exposure to TMAO, l-carnitine, and DMG and NAFLD risk, with a negative association being observed for betaine
PlexusDx's Precision Peptide Genetic Test analyzes 150+ genetic insights across GLP1R, GIPR, FTO, and MC4R variants that influence appetite, metabolic rate, and nutrient metabolism
By working synergistically, these peptides promote angiogenesis, collagen synthesis, cell migration, and exhibit anti-inflammatory properties
Theodoropoulos G Stem cells in colon cancer